21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System — RxCUI 1367436
RxNorm drug concept · Semantic clinical drug
RxCUI 1367436
Semantic clinical drug · SCD
● Current RxNorm concept 10 FDA products
10 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1367436
Official name21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asethinyl estradiol 15 MCG / etonogestrel 120 MCG per 24HR 3 Week Vaginal System; etonogestrel 0.12 MG / ethinyl estradiol 0.015 MG per 24HR 3 Week Vaginal System
FDA products mapped10
Package NDCs mapped10
Reported Medicaid activity (SDUD)298,425 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ethinyl Estradiol / Etonogestrel: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- No exact position is needed — the ring just needs to be inside the vagina, wherever feels comfortable. Compress it between your fingers and slide it in. You wear it continuously fo...
- How exactly do I use this ring — do I need to place it in a specific spot?
- Rinse it with cool water and reinsert it as soon as you can. How long it was out matters, so check the detailed instructions that came with your specific product — they'll tell you...
- The most common ones — vaginal discomfort, headaches, mood changes, nausea, and breast tenderness — are unpleasant but not dangerous. Spotting or irregular bleeding is also common,...
🕸️ Concept Web — How 21 DAY ethinyl estradiol 0.000625 MG/HR / etonog... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System
RxCUI 1367436 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Ethinyl estradiol
4124IN -
Etonogestrel
14584IN -
Ethinyl estradiol / etonogestrel
352376MIN
-
Ethinyl estradiol
-
Brand names 4
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
EluRyng
2266502BN -
Enilloring
2644703BN -
Haloette
2622917BN -
NuvaRing
710529BN
-
EluRyng
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ethinyl estradiol / etonogestrel Vaginal System
2201658SCDF -
Ethinyl estradiol / etonogestrel Vaginal Product
1367434SCDG -
Ethinyl estradiol / etonogestrel Vaginal System [EluRyng]
2266504SBDF -
Ethinyl estradiol / etonogestrel Vaginal System [Enilloring]
2644706SBDF -
Ethinyl estradiol / etonogestrel Vaginal System [Haloette]
2622920SBDF -
Ethinyl estradiol / etonogestrel Vaginal System [NuvaRing]
2201660SBDF -
EluRyng Vaginal Product
2266505SBDG -
Enilloring Vaginal Product
2644705SBDG - +4 more in this family
-
Ethinyl estradiol / etonogestrel Vaginal System
-
Clinical & branded drugs 10
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ethinyl estradiol 0.000625 MG/HR
1367432SCDC -
Etonogestrel 0.005 MG/HR
798355SCDC -
21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [EluRyng]
2266506SBD -
21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Enilloring]
2644707SBD -
21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Haloette]
2622921SBD -
21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [NuvaRing]
1367439SBD -
Ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [EluRyng]
2266503SBDC -
Ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [Enilloring]
2644704SBDC - +2 more in this family
-
Ethinyl estradiol 0.000625 MG/HR
Showing up to 8 concepts per family — 23 of 29 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ethinyl estradiol 0.000625 MG/HR
SCDC · 1367432 -
Etonogestrel 0.005 MG/HR
SCDC · 798355 -
Ethinyl estradiol / etonogestrel Vaginal System
SCDF · 2201658 -
Ethinyl estradiol / etonogestrel Vaginal Product
SCDG · 1367434
Brand-Name Concepts
-
21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [EluRyng]
SBD · 2266506 -
21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Enilloring]
SBD · 2644707 -
21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [NuvaRing]
SBD · 1367439 -
21 DAY ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR Vaginal System [Haloette]
SBD · 2622921 -
Ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [EluRyng]
SBDC · 2266503 -
Ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [Enilloring]
SBDC · 2644704 -
Ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [Haloette]
SBDC · 2622918 -
Ethinyl estradiol 0.000625 MG/HR / etonogestrel 0.005 MG/HR [NuvaRing]
SBDC · 1367437 -
Ethinyl estradiol / etonogestrel Vaginal System [EluRyng]
SBDF · 2266504 -
Ethinyl estradiol / etonogestrel Vaginal System [Enilloring]
SBDF · 2644706
📦 FDA Products & Package NDCs
10 products · 10 package NDCs
10 package NDCs map to RxCUI 1367436 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-7679-02 | 3 POUCH in 1 CARTON (0093-7679-02) / 21 d in 1 POUCH (0093-... | Etonogestrel and Ethinyl Estradiol | Teva Pharmaceuticals USA, Inc. | 2021-01-19 |
| 16714-0029-03 | 3 POUCH in 1 CARTON (16714-029-03) / 21 d in 1 POUCH (16714... | Etonogestrel and Ethinyl Estradiol Vaginal Ring | Northstar Rx LLC | 2023-11-01 |
| 42291-0478-03 | 3 POUCH in 1 CARTON (42291-478-03) / 21 d in 1 POUCH (42291... | Etonogestrel and Ethinyl Estradiol Vaginal | AvKARE | 2023-09-21 |
| 50090-5611-00 | 3 POUCH in 1 BOX (50090-5611-0) / 21 d in 1 POUCH | NUVARING | A-S Medication Solutions | 2021-08-12 |
| 50090-7663-00 | 1 POUCH in 1 BOX (50090-7663-0) / 21 d in 1 POUCH | NUVARING | A-S Medication Solutions | 2025-09-30 |
| 59212-0146-03 | 3 POUCH in 1 BOX (59212-146-03) / 21 d in 1 POUCH (59212-14... | NuvaRing | Advanz Pharma (US) Corp. | 2025-05-19 |
| 65162-0469-35 | 3 POUCH in 1 CARTON (65162-469-35) / 21 d in 1 POUCH (65162... | EluRyng | Amneal Pharmaceuticals LLC | 2019-12-16 |
| 66993-0605-36 | 3 POUCH in 1 BOX (66993-605-36) / 21 d in 1 POUCH (66993-60... | Etonogestrel/Ethinyl Estradiol | Prasco Laboratories | 2021-06-01 |
| 70700-0156-91 | 3 POUCH in 1 CARTON (70700-156-91) / 21 d in 1 POUCH (70700... | EnilloRing | Xiromed, LLC | 2023-08-15 |
| 78206-0146-03 | 3 POUCH in 1 BOX (78206-146-03) / 21 d in 1 POUCH (78206-14... | NuvaRing | Organon LLC | 2021-06-01 |
Observed labelers:
A-S Medication Solutions (2) ·
Advanz Pharma (US) Corp. (1) ·
Amneal Pharmaceuticals LLC (1) ·
AvKARE (1) ·
Northstar Rx LLC (1) ·
Organon LLC (1)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.